Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet

V.H.J. van der Velden*, F. Preijers, U. Johansson, T.M. Westers, A. Dunlop, A. Porwit, M.C. Bene, P. Valent, J. te Marvelde, O. Wagner-Ballon, U. Oelschlaegel, L. Saft, S. Kordasti, R. Ireland, E. Cremers, C. Alhan, C. Duetz, W. Hobo, N. Chapuis, M. FontenayP. Bettelheim, L. Eidenshink-Brodersen, P. Font, M.R. Loken, S. Matarraz, K. Ogata, A. Orfao, K. Psarra, D. Subira, D.A. Wells, M.G. Della Porta, K. Burbury, F. Bellos, E. Weiss, W. Kern, A. van de Loosdrecht

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

4 Citations (Web of Science)
Original languageEnglish
Number of pages12
JournalCytometry Part B-clinical Cytometry
DOIs
Publication statusE-pub ahead of print - 11 Dec 2021

Keywords

  • ELN
  • flow cytometry
  • MDS
  • pre-analytic issues
  • BONE-MARROW
  • REFRACTORY CYTOPENIA
  • CONSENSUS STATEMENTS
  • DIAGNOSTIC-CRITERIA
  • LOW-GRADE
  • CLASSIFICATION
  • MASTOCYTOSIS
  • STANDARDS
  • QUANTIFICATION

Cite this